ZERO WORLD RESEARCHLiterature database on amino acids & organic acids

Mitolnc controls cardiac BCAA metabolism and heart hypertrophy by allosteric activation of BCKDH.

Nucleic acids research2024Weiss M, Hettrich S, Hofmann T, et al.
Study designOther primary literature
SubjectHuman & animal

Record checks

Study design
Other primary literature
Subject
Human & animal
Publication year
2024
Source
doi.org
Abstract display
Shown here
Publication status
Active
Status checked
17 Aug 2026
Collected
3 Aug 2026
Freshness
Current
Review stage
Automated
Record status
Published

Abstract

Enzyme activity is determined by various different mechanisms, including posttranslational modifications and allosteric regulation. Allosteric activators are often metabolites but other molecules serve similar functions. So far, examples of long non-coding RNAs (lncRNAs) acting as allosteric activators of enzyme activity are missing. Here, we describe the function of mitolnc in cardiomyocytes, a nuclear encoded long non-coding RNA, located in mitochondria and directly interacting with the branched-chain ketoacid dehydrogenase (BCKDH) complex to increase its activity. The BCKDH complex is critical for branched-chain amino acid catabolism (BCAAs). Inactivation of mitolnc in mice reduces BCKDH complex activity, resulting in accumulation of BCAAs in the heart and cardiac hypertrophy via enhanced mTOR signaling. We found that mitolnc allosterically activates the BCKDH complex, independent of phosphorylation. Mitolnc-mediated regulation of the BCKDH complex constitutes an important additional layer to regulate the BCKDH complex in a tissue-specific manner, evading direct coupling of BCAA metabolism to ACLY-dependent lipogenesis.

MeSH

3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide)Allosteric RegulationAmino Acids, Branched-ChainAnimalsCardiomegalyHumansMaleMiceMice, Inbred C57BLMice, KnockoutMyocytes, CardiacRNA, Long NoncodingSignal TransductionTOR Serine-Threonine Kinases

DOI 10.1093/nar/gkae226

PMID 38567728

View source →